Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000277869 encodes a pseudogene related to the calponin 2 gene, sometimes described as "calponin 2 pseudogene" or by similar names. Pseudogenes are non-functional genomic DNA sequences similar to normal genes but typically unable to encode a functional protein, often due to accumulated mutations or lack of regulatory elements. While the functional calponin 2 gene (CNN2) is implicated in actin binding, cytoskeletal regulation, and multiple biological processes—including smooth muscle contraction, cell migration, and potentially cancer biology—pseudogenes such as ENSG00000277869 do not produce functional protein products and are not considered therapeutic drug targets or biologically active themselves. There is no evidence of disease association, druggability, or biomarker status for this pseudogene[2][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calponin 2 pseudogene.